Clinical trial Recruiting at 1 site Observational Ages 26 Weeks to 32 Weeks

Early prediction of lung injury in very preterm infants using EIT and lung ultrasound

Official title: Electrical Impedance Tomography and Lung Ultrasound Score in Early Prediction of Bronchopulmonary Dysplasia in Preterm and Very Low Birth Weight Infants.

Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07265583 · Data updated 2026-11-12

This project will test whether bedside Electrical Impedance Tomography (EIT) and lung ultrasound in stable preterm babies on non-invasive breathing support can spot uneven lung ventilation that predicts severe BPD or death by 36 weeks postmenstrual age.

More Preterm Birth trials

Quick facts

Study typeObservational
Ages26 Weeks to 32 Weeks
SexAll
Enrollment104 (estimated)
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
Academic / other
Locations1 site (Pavia)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedJuly 1, 2026
Study endsJuly 1, 2027
Registry record updatedDecember 5, 2025
Trial IDNCT07265583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are inborn very preterm infants (26–32 weeks' gestation and/or birthweight <1500 g) with respiratory distress syndrome who are on nCPAP or HFNC at 72 hours of life and whose parents provide consent.

Probably not a fit

Infants who are outborn, intubated and mechanically ventilated for more than 72 hours, have major congenital or genetic anomalies, skin conditions preventing EIT, or other life‑threatening comorbidities are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will enroll 104 very preterm infants (26–32 weeks' gestation and/or birthweight <1500 g) with respiratory distress syndrome who remain on non-invasive ventilation (nCPAP or HFNC) at 72 hours of life at the NICU in Pavia, Italy. Investigators will perform bedside Electrical Impedance Tomography (EIT) during the first weeks of life to quantify ventilation homogeneity and will collect standard lung ultrasound (LUS) scores. EIT-derived homogeneity parameters and LUS scores will be compared with clinical outcomes, specifically bronchopulmonary dysplasia grade 3 at 36 weeks postmenstrual age or death, to see if early ventilation inhomogeneity predicts later severe lung injury. All measurements are observational, will not alter routine care, and enrollment will be consecutive with informed parental consent.

Why it matters

Potential benefit: If successful, early detection of uneven ventilation could let clinicians tailor non-invasive support sooner and may reduce the risk of severe BPD.

How similar studies have gone: Prior neonatal work has used EIT and lung ultrasound to monitor regional aeration and ventilation, but using early EIT homogeneity measures specifically to predict severe BPD is relatively novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: preterm infants born between 26 and 32 weeks of gestational age and/or with a birth weight \< 1500g (very low birth weight infants - VLBW) with respiratory distress syndrome (RDS).

\- Exclusion Criteria: - outborn infants

* complex congenital malformations
* metabolic, chromosomal, or other genetic abnormalities
* pulmonary hypoplasia, congenital anomalies of surfactant proteins or other pulmonary abnormalities
* any skin anomalies
* need for mechanical ventilation \> 72h after birth
* any life-threatening comorbidity or any other medical condition which, in the opinion of the investigator, makes the patient unsuitable for inclusion.
* lack of parent consent.

Where it's running

  • Fondazione IRCCS Policlinico San Matteo
    Pavia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.